K Number
K060822
Device Name
VANTAGE INDIRECT OPHTHALMOSCOPE
Date Cleared
2006-05-23

(57 days)

Product Code
Regulation Number
886.1570
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Keeler Vamage Plus Indirect Ophthalmoscope is intended to examine the Cornea, aqueous, lens, vitreous and retina of the eye.
Device Description
The Vantage Plus is a head mounted Binocular Indirect ophthalmoscope designed to be used by trained personnel for illuminating and viewing parts of the eye such as the Cornea and retina when used in conjunction with an ophthalmic lens. The instrument has two main elements i) The illumination element ii) the viewing element. The illumination element consists of a 6Volt, 5Watt Xenon filament lamp, a condensing lens, IR filtration, User filters for diagnostic purposes, variable stop sizes for increasing/decreasing light aperture sizes, a projection lens and an illumination mirror used by the user to direct the light. The binocular Viewing element consists of low powered Viewing Lenses (+2 dioptre) and directional mirrors which are adjustable to obtain optimal views of the eye. The unit has adjustable illumination levels and is powered by the same power sources to that used on the Vantage (Re: 510(k) K942104). To improve the ease of use of the instrument, the Vantage Plus combines the Aperture selector control and the Viewing mirror adjustments to achieve optimal instrument setting with minimum fuss. This feature is not present on the Vantage (Re: 510(k) K942104).
More Information

No
The device description focuses on optical and mechanical components for illumination and viewing, with no mention of AI/ML algorithms or image processing for analysis or interpretation.

No.
The device is an ophthalmoscope intended for examination and viewing parts of the eye, which is a diagnostic purpose, not a therapeutic one.

Yes

The device is intended to "examine" various parts of the eye and includes "User filters for diagnostic purposes," indicating its role in the diagnostic process.

No

The device description clearly outlines multiple hardware components, including a lamp, lenses, mirrors, and a power source. It is a physical medical device, not software-only.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostic devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
  • Device Function: The Keeler Vantage Plus Indirect Ophthalmoscope is used to directly examine the internal structures of the eye (Cornea, aqueous, lens, vitreous, and retina) in vivo (within the living body). It illuminates and allows viewing of these structures.
  • Lack of Specimen Analysis: The device does not analyze any biological specimens taken from the patient.

Therefore, the function and intended use of this device clearly fall outside the scope of In Vitro Diagnostics.

N/A

Intended Use / Indications for Use

The Keeler Vamage Plus Indirect Ophthalmoscope is intended to examine the Cornea, aqueous, lens, vitreous and retina of the eye.

Product codes

HLI, HLJ

Device Description

The Vantage Plus is a head mounted Binocular Indirect ophthalmoscope designed to be used by trained personnel for illuminating and viewing parts of the eye such as the Cornea and retina when used in conjunction with an ophthalmic lens. The instrument has two main elements i) The illumination element ii) the viewing element. The illumination element consists of a 6Volt, 5Watt Xenon filament lamp, a condensing lens, IR filtration, User filters for diagnostic purposes, variable stop sizes for increasing/decreasing light aperture sizes, a projection lens and an illumination mirror used by the user to direct the light. The binocular Viewing element consists of low powered Viewing Lenses (+2 dioptre) and directional mirrors which are adjustable to obtain optimal views of the eye. The unit has adjustable illumination levels and is powered by the same power sources to that used on the Vantage (Re: 510(k) K942104). To improve the ease of use of the instrument, the Vantage Plus combines the Aperture selector control and the Viewing mirror adjustments to achieve optimal instrument setting with minimum fuss. This feature is not present on the Vantage (Re: 510(k) K942104).

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Cornea, aqueous, lens, vitreous and retina of the eye.

Indicated Patient Age Range

Not Found

Intended User / Care Setting

trained personnel

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K942104

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 886.1570 Ophthalmoscope.

(a)
Identification. An ophthalmoscope is an AC-powered or battery-powered device containing illumination and viewing optics intended to examine the media (cornea, aqueous, lens, and vitreous) and the retina of the eye.(b)
Classification. Class II (special controls). The device, when it is an AC-powered opthalmoscope, a battery-powered opthalmoscope, or a hand-held ophthalmoscope replacement battery, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.

0

Special 510K Summary

Keeler Instruments Inc

Submitter Contact Information:

Company Name/Address:

456, Parkway, Broomall, PA 19008MAY 23 2006
Company Phone No:(610) 353 4350
Company Fax No:(610) 353 7814
Contact Person:Mr. Eugene VanArsdale (Marketing Director).
Manufacturing Location:Keeler Ltd Clewer Hill Road, Windsor, Berkshire. SL4 4AA. United Kingdom.
Company Phone No:(44) 1753 857177
Company Fax No:(44) 1753 830247
Contact Person:Mr. Neil Atkins (Development Manager).
Device Information:
Device Trade Name:Vantage Plus Binocular Indirect Ophthalmoscope
Common Name:Ophthalmoscope
Class:II
Classification Panel:86
Product Code:HLI (AC) and HLJ (DC)
Regulation Number:886.1570
Substantial Equivalence:
Predicate Device:Vantage Binocular Indirect Ophthalmoscope.
510(k) No:K942104
Manufacturer:Keeler Ltd (FDA Registration No 1000391004) (Address as above).
Distributor:Keeler Instruments Inc (FDA Registration No 2519784) (Address as above).
Device Description:The Vantage Plus is a head mounted Binocular Indirect ophthalmoscope designed to be used by trained personnel for illuminating and viewing parts of the eye such as the Cornea and retina when used in conjunction with an ophthalmic lens. The instrument has two main elements i) The illumination element ii) the viewing element. The illumination element consists of a 6Volt, 5Watt Xenon filament lamp, a condensing lens, IR filtration, User filters for diagnostic purposes, variable stop sizes for increasing/decreasing light aperture sizes, a projection lens and an illumination mirror used by the user to direct the light. The binocular Viewing element consists of low powered Viewing Lenses (+2 dioptre) and

The binocular Viewing element consists of low powered Viewing Lenses (+2 dioptre) and directional mirrors which are adjustable to obtain optimal views of the eye. The unit has adjustable illumination levels and is powered by the same power sources to that used on the Vantage (Re: 510(k) K942104).

To improve the ease of use of the instrument, the Vantage Plus combines the Aperture selector control and the Viewing mirror adjustments to achieve optimal instrument setting with minimum fuss. This feature is not present on the Vantage (Re: 510(k) K942104).

Dia

그 | 강

D

K0608zz

1

Comparison of Technological Characteristics:

:

Comparison of Indirect Ophthalmoscope Technological Characteristics
CriteriaPredicate Device
Keeler Vantage
(Re:510(k) K942104)Keeler Vantage Plus (see note 4)
TypeBinocular (Headband Mounted)Binocular (Headband Mounted)
Illumination6V, 10 Watt Halogen Filament
Bulb6V, 5 Watt Xenon Filament Bulb
Safety Filter IR BlockerSelectablePermanent
Light Output (See note 1)954 Lux913 Lux
Blue FilterSelectableSelectable
Red Free FilterSelectableSelectable
DiffuserSelectableSelectable
Light aperture sizes (See note 2)Large (60mm)Large (60mm) +/-5%
Medium (45mm)Medium (45mm) +/-5%
Small (22mm)Small (22mm)+/-5%
Inter Pupillary Distance Adjustment52mm to 76mm
Lens Power Viewing Optics+2 Dioptre+2 Dioptre
AttachmentsHi-Mag
Teaching MirrorHi-Mag
Teaching Mirror
Power Sources (See Note 2)Wall Pack
Smart Pack
Wireless battery PackWall Pack
Smart Pack
Wireless Battery Pack
Note 1: Average light output from a selection of bulbs for a patch size of 60mm.
Note 2: Measurements taken from 440mm from the front of the instrument.Note 3: All Power supplies comply with relevant parts of BS EN 60601-1 and 60601-1-2.
Note 4: All testing has been carried out on a fully functional prototype.
Quality approvals:Keeler is an ISO 9001:2000 and BS EN 13485:2003 compliant company and are obliged to ensure
that our operating and design practices fully comply. As part of the design process, all necessary risk
analysis, risk management, design verification and validation are conducted to ensure that the safety
and effectiveness of product designs either meet or surpass the product specification and comply too
the relevant standards.
Risk Management:Completed as per BS EN ISO 14971:2001
Light Hazard:The Vantage Plus has been tested in accordance with BS EN ISO 15004:1998 and is within the limits
specified for Optical radiation Hazard (Section 6.3) (See separate report under Technical
Documentation).
Electrical:The Vantage Plus is using the same Power Sources as the Vantage detailed in 510(k) K942104. All
power sources are compliant with BS EN 60601-1 and 60601-1-2 and Keeler has not received any
adverse reports on these products (See separate reports under Technical Documentation).
Explosion:Low probability. All measures have been taken to reduce the risk of explosion by using non-
explosive materials, ensuring the product meets all of the relevant electrical safety requirements and
detailed user instructions defining the requirements for safe usage of the instrument.
Fire Hazard:Low Probability. All measures have been taken to use self extinguishing materials which are either
HB or VO rated. The system is illuminated using a 5watt Xenon lamp and all materials used in the
vicinity are specifically designed to operate in high temperature environments safely.
Surface Temperature:Complies with BS EN ISO 60601-1 for temperature of external surfaces and controls. Caution in use instructions indicates 'Do not remove bulb whilst hot'.

2

Image /page/2/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle with its wings spread, forming a human-like figure. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle.

JUL 3 2008 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Keeler Instruments, Inc. c/o Mr. Eugene VanArsdale Marketing Director 456 Parkway Broomall, PA 19008

Re: K060822

Trade/Device Name: Vantage Plus Binocular Indirect Ophthalmoscope Regulation Number: 21 CFR 886.1570 Regulation Name: Ophthalmoscope Regulatory Class: II Product Code: HLI and HLJ Dated: May 4, 2006 Received: May 8, 2006

Dear Mr. VanArsdale:

This letter corrects our substantially equivalent letter of May 23, 2006.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

3

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Malvina B. Edwards, ud

Malvina B. Eydelman, M.I Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Copy

Indications for Use

510(k) Number (if known):

Device Name: Vantage Plus Binocular Indirect Ophthalmoscope

Indications for Use:

i

The Keeler Vamage Plus Indirect Ophthalmoscope is intended to examine the Cornea, aqueous, lens, vitreous and retina of the eye.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Oft)
Division of Ophthalmic Ear,
Nose and Throat Devises

510(k) Number K060822

Page 1 of 1

22